Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism
December 2012
Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism.
It's the first of the new oral anticoagulants approved to treat deep venous thrombosis or pulmonary embolism...and reduce the risk of a subsequent venous thromboembolism.
Xarelto has advantages over warfarin for treating venous clots...no anticoag monitoring, fewer interactions, and no bridging with low-molecular-weight heparin because of its fast onset.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote